您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (S1): 77-79.

• 临床医学 • 上一篇    下一篇

晚期胃癌患者血清TP表达与含替吉奥方案化疗疗效的相关性研究

徐光辉1, 李玉1, 刘忠伦2, 胡楠1   

  1. 1. 连云港市第一人民医院 肿瘤科, 江苏 连云港 222002;
    2. 连云港市第一人民医院 检验科, 江苏 连云港 222002
  • 收稿日期:2014-11-30 发布日期:2014-12-30
  • 基金资助:
    连云港市卫生局课题(指令性1216)

Correlations between serum levels of TP and clinical outcome in patients with advanced gastric cancer receiving S-1 regimen chemotherapy

XU Guang-hui1, LI Yu1, LIU Zhong-lun2, HU Nan1   

  1. 1. Department of Oncological Chemotherapy, The First People's Hospital of Lianyungang , Lianyungang 222002, Jiangsu China;
    2. Department of Laboratory, The First People's Hospital of Lianyungang , Lianyungang 222002, Jiangsu China
  • Received:2014-11-30 Published:2014-12-30
  • Contact: 李玉, E-mail: ly651226@163.com E-mail:ly651226@163.com

PDF (PC)

131

摘要： 目的 探讨胸苷磷酸化酶(TP)在晚期胃癌患者血清中的表达及其与含替吉奥方案化疗疗效的相关性。方法 收集46例接受以替吉奥为基础的一线化疗方案治疗的晚期胃癌患者化疗前的血清标本,运用酶联免疫吸附试验(ELISA)方法检测血清中TP的表达水平,分析其与化疗疗效及预后的相关性。结果 肝脏转移患者TP表达水平低于无肝脏转移患者(P<0.01),TP高表达与低表达患者的临床获益率差异无统计学意义。TP高表达患者的中位无进展生存期(PFS)长于低表达患者(6.5个月vs 5.0个月,P＝0.026)。结论 以替吉奥为基础化疗的晚期胃癌患者中,TP高表达者预后相对较好。

关键词: 预后, 胸苷磷酸化酶, 胃癌, 替吉奥

Abstract: Objective To investigate the correlations between serum levels of TP and clinical outcome in patients with advanced gastric cancer receiving S-1 regimen chemotherapy. Methods Serum samples before chemotherapy were collected from 46 patients receiving first-line S-1 regimen chemotherapy from Jun 2012 to Jan 2014, TP levels were analyzed using ELISA assay. Results TP expressions were significantly lower in patients with liver metastasis than those in patients without liver metastasis (P<0.01). There was no difference in clinical beneficial rate (CBR) between patients with high and low levels of TP. The median progression-free survival (PFS) in patients with high level of TP was longer than those with low level of TP (6.5 m vs 5.0 m,P=0.026 ). Conclusion In patients receiving first-line S-1 regimen chemotherapy, those with high level of TP may get better prognosis than those with low level of TP.

Key words: Gastric cancer, Thymidine phosphorylase, S-1, Prognosis

中图分类号: 

  • R735
[1] 夏传生,李娜萍,李明显,等.胸苷磷酸化酶及血管内皮生长因子在胃腺癌组织中的表达及其临床意义[J].华中科技大学学报: 医学版,2011,40(3): 343-346.
[2] Hata K,Fujiwaki R,Nakayama K,et al.Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor [J].Anticancer Res,1999,20(5C): 3941-3949.
[3] Fujiwaki R,Hata K,Nakayama K,et al.Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer[J].J Clin Oncol,2000,18(23): 3946-3951.
[4] Matsuura T,Kuratate I,Teramachi K,et al.Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas[J].Cancer Res,1999,59(19): 5037-5040.
[5] Takebayashi Y,Miyadera K,Akiyama S,et al.Expression of thymidine phosphorylase in human gastric carcinoma[J].Cancer Science,1996,87(3): 288-295.
[6] Fujioka S,Yoshida K,Yanagisawa S,et al.Angiogenesis in pancreatic carcinoma [J].Cancer,2001,92(7): 1788-1797.
[7] 何琼,高静,王婷婷,等.晚期胃癌患者血清 TS、TP 表达水平与氟尿嘧啶为基础的化疗疗效及预后的相关性[J].中国癌症杂志,2013,23(4): 292-297.
[8] Nishimura G,Terada I,Kobayashi T,et al.Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy [J].Oncol Rep,2002,9(3): 479-482.
[9] Zhou J,Xiao Y S,Tang Z Y,et al.Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration [J].J Cancer Res Clin Oncol,2005,131(8): 547-551.
[1] 李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[2] 刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[3] 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[4] 贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[5] 杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[6] 杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[7] 张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84.
[8] 刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.
[9] 陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[10] 郭振江,王宁,赵光远,杜立强,崔朝勃,刘防震. 基于机器学习建立术前预测近端胃癌食管切缘阳性模型[J]. 山东大学学报 (医学版), 2024, 62(7): 78-83.
[11] 郭姝画,樊扬,田风,王传新,杜鲁涛,李培龙,郭兴,徐硕. 微原纤维相关蛋白3在调控胶质瘤干细胞间充质表型转化中的作用[J]. 山东大学学报 (医学版), 2024, 62(6): 9-16.
[12] 魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[13] 刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[14] 郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47.
[15] 杨雪彦,吴寅平,吕丽,赵泽华,马行宇,李凤彩,王凯,范玉琛. 单核细胞与淋巴细胞比值动态变化对慢加急性乙型肝炎肝衰竭预后的诊断价值[J]. 山东大学学报 (医学版), 2024, 62(3): 61-69.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发